Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Sarah Worfolk × Clear Filters

1 results found

Development of oncolytic HSV-1 to activate necroptosis induced anticancer immunity against glioblastoma

This research uses engineered oncolytic viruses that preferentially infect cancer cells as a platform to deliver a new treatment strategy for glioblastoma.


Grant type
Other
Area of Research
Cancer
Competition
CRS Doctoral Research Awards
Province
Ontario
Start Date
2026